- Home
- HMY vs CORT Comparison
HMY vs CORT Comparison
Compare HMY & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HMY
- CORT
- Stock Information
- Founded
- HMY 1950
- CORT 1998
- Country
- HMY South Africa
- CORT United States
- Employees
- HMY N/A
- CORT N/A
- Industry
- HMY Precious Metals
- CORT Biotechnology: Pharmaceutical Preparations
- Sector
- HMY Basic Materials
- CORT Health Care
- Exchange
- HMY Nasdaq
- CORT Nasdaq
- Market Cap
- HMY 7.5B
- CORT 7.1B
- IPO Year
- HMY N/A
- CORT N/A
- Fundamental
- Price
- HMY $14.07
- CORT $54.63
- Analyst Decision
- HMY Sell
- CORT Strong Buy
- Analyst Count
- HMY 3
- CORT 4
- Target Price
- HMY $6.60
- CORT $99.75
- AVG Volume (30 Days)
- HMY 6.8M
- CORT 1.1M
- Earning Date
- HMY 01-01-0001
- CORT 04-30-2025
- Dividend Yield
- HMY 1.08%
- CORT N/A
- EPS Growth
- HMY 16.30
- CORT 30.85
- EPS
- HMY 0.88
- CORT 1.23
- Revenue
- HMY $3,553,951,394.00
- CORT $675,040,000.00
- Revenue This Year
- HMY $17.62
- CORT $36.81
- Revenue Next Year
- HMY $7.93
- CORT $29.94
- P/E Ratio
- HMY $15.52
- CORT $44.11
- Revenue Growth
- HMY 16.84
- CORT 39.94
- 52 Week Low
- HMY $7.97
- CORT $20.84
- 52 Week High
- HMY $14.38
- CORT $75.00
- Technical
- Relative Strength Index (RSI)
- HMY 75.58
- CORT 38.68
- Support Level
- HMY $12.50
- CORT $56.52
- Resistance Level
- HMY $13.12
- CORT $61.09
- Average True Range (ATR)
- HMY 0.40
- CORT 2.49
- MACD
- HMY 0.12
- CORT 0.09
- Stochastic Oscillator
- HMY 88.38
- CORT 11.51
About HMY Harmony Gold Mining Company Limited
Harmony Gold Mining Co Ltd is a gold mining and exploration company having operations in South Africa and Papua New Guinea (PNG). Its projects include Bambanani, Joel, Masimong, Phakisa, Target 1, Tshepong, Unisel, Doornkop, and Kusasalethu. The group's segments are Tshepong Operations, Bambanani, Joel, Doornkop, Moab Khotsong, Hidden Valley, Target 1, Kusasalethu, Masimong, Unisel, and all other surface operations.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.